Thirteen out of the 14 tumors that expressed ALK-I19 also showed strong ALK expression, as defined by > 50% of tumor containing areas showing strong ALK immunostaining, a criterion used in a previous publication [27]. This evidence concerns the gene ALK and neoplasm.